CEL-SCI Corp (CVM)
1.22
+0.08 (7.02%)
Upcoming Events
Latest Headlines
CEL-SCI Multikine Phase 3 data accepted by Oral Oncology journal
July 30, 2026 8:31 AM - StreetInsider
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
July 30, 2026 8:31 AM - BizWire
CEL-SCI launches phase 3 confirmatory study for head and neck cancer drug
July 13, 2026 8:01 AM - StreetInsider
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
July 13, 2026 8:00 AM - BizWire
Form ARS CEL SCI CORP For: Sep 30
July 2, 2026 5:08 PM - SEC Filing
Form DEF 14A CEL SCI CORP For: Jun 23
July 2, 2026 5:02 PM - SEC Filing
Form 4 CEL SCI CORP For: Jun 30 Filed by: TALOR EYAL
July 1, 2026 8:41 AM - SEC Filing
Form 4 CEL SCI CORP For: Jun 30 Filed by: PRICHEP PATRICIA B
July 1, 2026 8:38 AM - SEC Filing
Form 4 CEL SCI CORP For: Jun 30 Filed by: KERSTEN GEERT R
July 1, 2026 8:33 AM - SEC Filing
CEL-SCI signs distribution deal with Saudi Amarox for cancer drug
June 24, 2026 8:00 AM - StreetInsider
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
June 24, 2026 8:00 AM - BizWire
Form 8-K CEL SCI CORP For: Jun 14
June 16, 2026 5:04 PM - SEC Filing
CEL-SCI closes $2.5M stock offering at $1.00 per share
June 16, 2026 4:01 PM - StreetInsider
CEL-SCI Announces Closing of Offering
June 16, 2026 4:01 PM - BizWire
CEL-SCI plans U.S. study and Saudi deal for head and neck drug
June 16, 2026 8:02 AM - StreetInsider
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
June 16, 2026 8:00 AM - BizWire
Form 424B5 CEL SCI CORP
June 15, 2026 5:01 PM - SEC Filing
CEL-SCI prices $2.5 million share offering at $1.00 per share
June 15, 2026 3:02 AM - StreetInsider
CEL-SCI Corporation Announces Pricing of Offering
June 14, 2026 7:03 PM - BizWire
CEL-SCI to sign Saudi Arabia distribution deal for Multikine at BIO 2026
June 12, 2026 8:00 AM - StreetInsider
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
June 12, 2026 8:00 AM - BizWire
Form RW CEL SCI CORP
May 27, 2026 5:00 PM - SEC Filing
Form RW CEL SCI CORP
May 19, 2026 6:02 AM - SEC Filing
Form 4 CEL SCI CORP For: May 14 Filed by: KERSTEN GEERT R
May 18, 2026 8:03 AM - SEC Filing
CEL-SCI Reports Fiscal Second Quarter 2026 Results
May 18, 2026 8:00 AM - BizWire
Form 10-Q CEL SCI CORP For: Mar 31
May 15, 2026 5:01 PM - SEC Filing
Form 8-K CEL SCI CORP For: May 11
May 14, 2026 5:16 PM - SEC Filing
Form 4 CEL SCI CORP For: May 13 Filed by: KERSTEN GEERT R
May 14, 2026 8:57 AM - SEC Filing
Form 8-K CEL SCI CORP For: May 11
May 13, 2026 4:44 PM - SEC Filing
CEL-SCI closes $7.2 million public offering of common stock
May 13, 2026 3:00 PM - StreetInsider
CEL-SCI Announces Closing of Public Offering
May 13, 2026 3:00 PM - BizWire
Form 424B4 CEL SCI CORP
May 13, 2026 6:04 AM - SEC Filing
Form EFFECT CEL SCI CORP
May 12, 2026 6:07 AM - SEC Filing
CEL-SCI prices $7.2 million public offering at $1.20 per share
May 11, 2026 8:11 PM - StreetInsider
CEL-SCI Corporation Announces Pricing of Public Offering
May 11, 2026 8:11 PM - BizWire
CEL-SCI partners with Amarox for Multikine distribution in Saudi Arabia
May 11, 2026 8:00 AM - StreetInsider
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
May 11, 2026 8:00 AM - BizWire
Full Article List
